Publication:
Retrospective analysis of corticosteroid treatment in Stevens-Johnson syndrome and/or toxic epidermal necrolysis over a period of 10 years in Vajira Hospital, Navamindradhiraj University, Bangkok

dc.contributor.authorWanjarus Roongpisuthipongen_US
dc.contributor.authorSirikarn Prompongsaen_US
dc.contributor.authorTheerawut Klangjareonchaien_US
dc.contributor.otherVajira Hospitalen_US
dc.contributor.otherNavamindradhiraj Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-11-09T02:54:29Z
dc.date.available2018-11-09T02:54:29Z
dc.date.issued2014-01-01en_US
dc.description.abstractBackground. Stevens-Johnson syndrome (SJS) and/or toxic epidermal necrolysis (TEN) are uncommon and life-threatening drug reaction associated with a high morbidity and mortality. Objective. We studied SJS and/or TEN by conducting a retrospective analysis of 87 patients treated during a 10-year period. Methods. We conducted a retrospective review of the records of all patients with a diagnosis of SJS and/or TEN based on clinical features and histological confirmation of SJS and/or TEN was not available at the Department of Medicine, Vajira hospital, Bangkok, Thailand. The data were collected from two groups from 2003 to 2007 and 2008 to 2012. Results. A total of 87 cases of SJS and/or TEN were found, comprising 44 males and 43 females whose mean age was 46.5 years. The average length of stay was 17 days. Antibiotics, anticonvulsants, and allopurinol were the major culprit drugs in both groups. The mean SCORTEN on admission was 2.1 in first the group while 1.7 in second the group. From 2008 to 2012, thirty-nine patients (76.5%) were treated with corticosteroids while only eight patients (22.2%) were treated between 2003 and 2007. The mortality rate declined from 25% from the first group to 13.7% in the second group. Complications between first and second groups had no significant differences. Conclusions. Short-term corticosteroids may contribute to a reduced mortality rate in SJS and/or TEN without increasing secondary infection. Further well-designed studies are required to compare the effect of corticosteroids treatment for SJS and/or TEN. © 2014 Wanjarus Roongpisuthipong et al.en_US
dc.identifier.citationDermatology Research and Practice. Vol.2014, (2014)en_US
dc.identifier.doi10.1155/2014/237821en_US
dc.identifier.issn16876113en_US
dc.identifier.other2-s2.0-84904112017en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34645
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904112017&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleRetrospective analysis of corticosteroid treatment in Stevens-Johnson syndrome and/or toxic epidermal necrolysis over a period of 10 years in Vajira Hospital, Navamindradhiraj University, Bangkoken_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904112017&origin=inwarden_US

Files

Collections